Clinical trials are a clear area where mobile engagement and big data have serious potential, but it’s still a largely untapped use case. There have been a lot of stories recently about the opportunities in that space, but also on the challenges companies have encountered in implementing them. At least one abandoned study and one failed company can attest to those.
In a release, Wil Yu, Special Assistant for Innovations at ONC, said, “We are very excited about the winning applications. The popHealth tool is a cutting-edge technology that was able to support a highly technical competition. The winning teams displayed impressive levels of understanding in the areas of meaningful use and provider-patient interaction, which resulted in unique and useful solutions. We look forward to seeing advancements to the teams’ solutions in the future.”
Wil Yu, ONC’s special assistant for innovations – “We seek breakthrough solutions to nuanced issues; some are ready for the marketplace and some are prototypes, but all will have a great potential to benefit Americans. Ask Dory and My Cancer Genome are examples of results that innovation challenges can incentivize and deliver – we’re really excited to see their impact.”